Tracing Spatiotemporal T790M Heterogeneity in Patients with EGFR-Mutant Advanced NSCLC after Acquired Resistance to EGFR TKIs

被引：0
|
作者：
Zhang, Yi-Chen
Pi, Can
Ke, E-E
Chen, Zhi-Hong
Su, Jian
Dong, Zhong-Yi
Xu, Chong-Rui
Tu, Hai-Yan
Yan, Hong-Hong
Zhong, Wen-Zhao
Yang, Jin-Ji
Zhang, Xu-Chao
Wu, Yi Long
Zhou, Qing
机构：
[1] Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China
[2] GGH, Guangzhou, Guangdong, Peoples R China
[3] Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
Acquired resistance; EGFR TKIs; spatiotemporal heterogeneity; T790M;
D O I：
10.1016/j.jtho.2016.11.1762
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.02b-095
引用
收藏
页码：S1249 / S1249
页数：1
相关论文
共 50 条
  • [21] Epidermal growth factor receptor T790M mutation as a prognostic factor in EGFR-mutant non-small cell lung cancer patients that acquired resistance to EGFR tyrosine kinase inhibitors
    Ma, Guangzhi
    Zhang, Jing
    Jiang, Hai
    Zhang, Nannan
    Yin, Liyuan
    Li, Wen
    Zhou, Qinghua
    ONCOTARGET, 2017, 8 (59) : 99429 - 99437
  • [22] Clinical Outcomes in Advanced EGFR-Mutant NSCLC Patients Treated with First-Generation EGFR TKIs Followed by Subsequent Osimertinib
    Yao, Y.
    Cheng, J.
    Kang, J.
    Li, X.
    Chen, H.
    Zhou, Q.
    Xu, C.
    Zhang, X.
    Su, J.
    Yan, H.
    Wu, Y.
    Yang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S671 - S671
  • [23] Association between advanced NSCLC T790M EGFR-TKI secondary resistance and prognosis A observational study
    Wang, Yuli
    Wei, Yuan
    Ma, Xiaoping
    Ma, Xinyu
    Gong, Ping
    MEDICINE, 2018, 97 (28)
  • [24] Osimertinib benefit in EGFR-mutant NSCLC patients with T790M-mutation detected by circulating tumour DNA
    Remon, J.
    Caramella, C.
    Jovelet, C.
    Lacroix, L.
    Lawson, A.
    Smalley, S.
    Howarth, K.
    Gale, D.
    Green, E.
    Plagnol, V.
    Rosenfeld, N.
    Planchard, D.
    Bluthgen, M. V.
    Gazzah, A.
    Pannet, C.
    Nicotra, C.
    Auclin, E.
    Soria, J. C.
    Besse, B.
    ANNALS OF ONCOLOGY, 2017, 28 (04) : 784 - 790
  • [25] Combination of Angiogenesis Inhibitor and EGFR-TKIs in Advanced NSCLC Patients Who Developed Acquired Resistance
    Song, Xia
    Tian, Ruifen
    Guo, Yi
    Wang, Rong
    Zhang, Xia
    Guo, Wei
    Zhu, Haibo
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S409 - S409
  • [26] Usefulness of Nanofluidic Digital PCR Arrays to Quantify T790M Mutation in EGFR-mutant Lung Adenocarcinoma
    Isobe, Kazutoshi
    Hata, Yoshinobu
    Tochigi, Naobumi
    Kaburaki, Kyohei
    Kobayashi, Hiroshi
    Makino, Takashi
    Otsuka, Hajime
    Ishida, Fumiaki
    Hirota, Nao
    Sano, Go
    Sugino, Keishi
    Sakamoto, Susumu
    Takai, Yujiro
    Shibuya, Kazutoshi
    Iyoda, Akira
    Homma, Sakae
    CANCER GENOMICS & PROTEOMICS, 2015, 12 (01) : 31 - 37
  • [27] Dual Inhibition of EGFR with Afatinib and Cetuximab in Kinase Inhibitor-Resistant EGFR-Mutant Lung Cancer with and without T790M Mutations
    Janjigian, Yelena Y.
    Smit, Egbert F.
    Groen, Harry J. M.
    Horn, Leora
    Gettinger, Scott
    Camidge, D. Ross
    Riely, Gregory J.
    Wang, Bushi
    Fu, Yali
    Chand, Vikram K.
    Miller, Vincent A.
    Pao, William
    CANCER DISCOVERY, 2014, 4 (09) : 1036 - 1045
  • [28] Targeting EGFR T790M mutation in NSCLC: From biology to evaluation and treatment
    Passaro, Antonio
    Guerini-Rocco, Elena
    Pochesci, Alessia
    Vacirca, Davide
    Spitaleri, Gianluca
    Catania, Chiara Matilde
    Rappa, Alessandra
    Barberis, Massimo
    de Marinis, Filippo
    PHARMACOLOGICAL RESEARCH, 2017, 117 : 406 - 415
  • [29] Performance of different methods for detecting T790M mutation in the plasma of patients with advanced NSCLC after developing resistance to first-generation EGFR-TKIs in a real-world clinical setting
    Hou, Tongtong
    Zeng, Jiahao
    Xu, Hanyan
    Su, Shanshan
    Ye, Junru
    Li, Yuping
    MOLECULAR AND CLINICAL ONCOLOGY, 2022, 16 (04)
  • [30] Lessons learned from routine, targeted assessment of liquid biopsies for EGFR T790M resistance mutation in patients with EGFR mutant lung cancers
    Mondaca, Sebastian
    Offin, Michael
    Borsu, Laetitia
    Myers, Mackenzie
    Josyula, Sowmya
    Makhnin, Alex
    Shen, Ronglai
    Riely, Gregory J.
    Rudin, Charles M.
    Ladanyi, Marc
    Yu, Helena A.
    Li, Bob T.
    Arcila, Maria E.
    ACTA ONCOLOGICA, 2019, 58 (11) : 1634 - 1639
12345